Bruker (BRKR) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Bruker · Health Care · ref. ETF XLV · 51 calls · price $59.25
What the company does: Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions.
📈 Bruker (BRKR) stock price
$59.25+77.1% over range
Aug 28, 25low $29.35 · high $64.34Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
57% recommend buying · 7 analysts
📊 JPI status : Bruker has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 BRKR price target & analyst consensus — price $59.25
The price target · all analysts combined (7 targets)
Highest target · 2 firms of 7$70+18.1%
Median target · of 7 targets$60+1.3%
Lowest target · 2 firms of 7$45-24.1%
Current price$59.25
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
457%
$60 ↔ $70
Below
343%
$45 ↔ $53
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Guggenheim — 77% of its targets hit on this sector (52 calls tested). It aims for $70 (+18 %), call made on June 30, 2026, maturing on June 30, 2027 (59 d ago).
The 2 reliable analysts
$61.50+3.8 %
The 5 other firms
$60+1.3 %
How to read it: the 2 reliable firms are not filtered by optimism — 1 aim above the price, 1 below, hence their $61.50 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy457%
Hold343%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BRKR price target all
All 51 calls, one by one, with our verdict on each firm.
→ See all 51 targets, analyst by analyst💡 The best analysts on BRKR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BRKR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Bruker? The JPI assistant answers using our backtest data.
💰 Bruker dividend: yield, history & growth › open the full page
0.33%annual yield
That's ~$0.20 per share per year.
📈 Bruker fundamentals: valuation, margins & growth › open the full page
P/E —Net margin -2.0 %Revenue growth +5.2 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 12 %
2023
Rev +17%Profit +44%
2024
Rev +14%Profit −74%
2025
Rev +2%Profit −120%
🔎 Detailed analyses
🏛️ Which US Congress members hold Bruker (BRKR)?
1 Congress member has disclosed BRKR buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Bob Gibbs 1× · 38%
✅ Historical analyst reliability on BRKR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Needham ↗ | 100% | +51.5% | 2 |
| Jefferies ↗ | 100% | +33.8% | 3 |
| Leerink Swann | 100% | +24.2% | 2 |
| UBS ↗ | 75% | +9.2% | 8 |
| Cantor Fitzgerald ↗ | 67% | +32.9% | 3 |
| Goldman Sachs ↗ | 57% | +10.1% | 7 |
| SVB Leerink | 57% | +9.9% | 7 |
| B of A Securities ↗ | 56% | +3.9% | 9 |
| Wells Fargo ↗ | 50% | +9.3% | 8 |
| Barclays ↗ | 50% | +4.3% | 10 |
See the other 5 firms
| JP Morgan ↗ | 0% | -48.1% | 2 |
| Guggenheim ↗ | 0% | -16.2% | 3 |
| Cleveland Research | 0% | -11.9% | 2 |
| Citigroup ↗ | 33% | -10.6% | 9 |
| Morgan Stanley ↗ | 50% | -11.0% | 2 |
📊 What $1,000 invested in Bruker would be worth › open the full page
In short — $1,000 invested in Bruker 10 years ago would be worth $2,480 today, i.e. +10%/yr on average. Best year: 2019 (+71%), worst: 2024 (-20%). Price performance, excluding dividends.
If I'd invested $1,000 in Bruker
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,027 | +3% |
| 3 years ago | $880 | -12% |
| 5 years ago | $1,112 | +11% |
Return by year (Bruker)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +28% | $1,277 (+28%) |
| 2025 | -20% | $1,027 (+3%) |
| 2024 | -20% | $819 (-18%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Bruker
Loading news…
📋 All analyst calls on BRKR
Filtered on — · ✕ show all
■ Neutral neutral · not a buy · 🎯$53
Price at call : $51.27 — gap to target +3%
Today : $59.25 — gap to target -11%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
■ Neutral neutral · not a buy · 🎯$60
Price at call : $60.58 — gap to target -1%
Today : $59.25 — gap to target +1%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Leerink Partners ↗
Jul 7, 26
▲ Outperform · 🎯$70
Price at call : $57.21 — upside +22%
Today : $59.25 — upside +18%
🎯 on BRKR : no call matured yet · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
Guggenheim ↗
Jun 29, 26
▲ Buy · 🎯$70
Price at call : $60.18 — upside +16%
Today : $59.25 — upside +18%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
▲ Overweight · 🎯$60
Price at call : $60.89 — upside -1%
Today : $59.25 — upside +1%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Overweight · 🎯$65
Price at call : $57.24 — upside +14%
Today : $59.25 — upside +10%
🎯 on BRKR : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
■ Neutral neutral · not a buy · 🎯$45
Price at call : $44.16 — gap to target +2%
Today : $59.25 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
■ Neutral neutral · not a buy · 🎯$44
Price at call : $44.16 — gap to target -0%
Today : $59.25 — gap to target -26%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
See the other 43 calls, newest to oldest
■ Hold neutral · not a buy · 🎯$45
Price at call : $44.16 — gap to target +2%
Today : $59.25 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Overweight · 🎯$53
Price at call : $44.16 — upside +20%
Today : $59.25 — upside -11%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Overweight · 🎯$45
Price at call : $38.94 — upside +16%
Today : $59.25 — upside -24%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Overweight · 🎯$45
Price at call : $39.48 — upside +14%
Today : $59.25 — upside -24%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Guggenheim ↗
Mar 30, 26
▲ Buy · 🎯$50
Price at call : $36.12 — upside +38%
Today : $59.25 — upside -16%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
■ Neutral neutral · not a buy · 🎯$40
Price at call : $38.12 — gap to target +5%
Today : $59.25 — gap to target -32%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
Goldman Sachs ↗
Feb 13, 26
▼ Sell · 🎯$35
Price at call : $38.12 — upside -8%
Today : $59.25 — upside -41%
🎯 on BRKR : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
■ Hold neutral · not a buy · 🎯$43
Price at call : $38.12 — gap to target +13%
Today : $59.25 — gap to target -27%
🎯 on BRKR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
▲ Overweight · 🎯$50
Price at call : $38.12 — upside +31%
Today : $59.25 — upside -16%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
Guggenheim ↗
Jan 26, 26
▲ Buy · 🎯$58
Price at call : $47.67 — upside +22%
Today : $59.25 — upside -2%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
in progress (365j)
matures : Jan 26, 27
matures : Jan 26, 27
■ Neutral neutral · not a buy · 🎯$53
Price at call : $49.84 — gap to target +6%
Today : $59.25 — gap to target -11%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Jan 16, 27
matures : Jan 16, 27
■ Hold neutral · not a buy · 🎯$53
Price at call : $52.48 — gap to target +1%
Today : $59.25 — gap to target -11%
🎯 on BRKR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Guggenheim ↗
Jan 5, 26
▲ Buy · 🎯$53
Price at call : $52.67 — upside +1%
Today : $59.25 — upside -11%
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.25 — upside -7%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.25 — upside -7%
🎯 on BRKR : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wells Fargo ↗
Dec 15, 25
▲ Overweight · 🎯$55
Price at call : $44.96 — upside +22%
Today : $59.25 — upside -7%
🎯 on BRKR : 100% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
B of A Securities ↗
Dec 15, 25
▲ Buy · 🎯$60
Price at call : $45.67 — upside +31%
Today : $59.25 — upside +1%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wolfe Research ↗
Dec 10, 25
▲ Outperform · 🎯$60
Price at call : $46.37 — upside +29%
Today : $59.25 — upside +1%
🎯 on BRKR : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
Goldman Sachs ↗
Dec 9, 25
▼ Sell · 🎯$40
Price at call : $45.36 — upside -12%
Today : $59.25 — upside -32%
🎯 on BRKR : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Rothschild & Co
Nov 20, 25
▲ Buy · 🎯$60
Price at call : $43.84 — upside +37%
Today : $59.25 — upside +1%
🎯 on BRKR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
Wells Fargo ↗
Nov 5, 25
▲ Overweight · 🎯$48
Price at call : $39.31 — upside +22%
Today : $59.25 — upside -19%
🎯 on BRKR : 100% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
■ Hold neutral · not a buy · 🎯$42
Price at call : $40.2 — gap to target +4%
Today : $59.25 — gap to target -29%
🎯 on BRKR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
■ Neutral neutral · not a buy · 🎯$43
Price at call : $40.2 — gap to target +7%
Today : $59.25 — gap to target -27%
🎯 on BRKR : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$45
Price at call : $40.38 — upside +11%
Today : $59.25 — upside -24%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$40
Price at call : $36.98 — upside +8%
Today : $59.25 — upside -32%
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
Wells Fargo ↗
Aug 5, 25
▲ Overweight · 🎯$50
Price at call : $30.66 — upside +63%
Today : $59.25 — upside -16%
Expected +63% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 100% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+67.2%
stock +67% · XLV +26%
matured Aug 5, 26
■ Hold neutral · not a buy · 🎯$40
Price at call : $32.07 — gap to target +25%
Today : $59.25 — gap to target -32%
🎯 on BRKR : no call matured yet · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
■ Neutral neutral · not a buy · 🎯$38
Price at call : $32.07 — gap to target +18%
Today : $59.25 — gap to target -36%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
▲ Overweight · 🎯$43
Price at call : $32.07 — upside +34%
Today : $59.25 — upside -27%
Expected +34% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+63.6%
stock +64% · XLV +24%
matured Aug 4, 26
▲ Buy · 🎯$60
Price at call : $32.07 — upside +87%
Today : $59.25 — upside +1%
Expected +87% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 49.1% · +10.3% (112 calls)
+63.6%
stock +64% · XLV +24%
matured Aug 4, 26
B of A Securities ↗
Jun 26, 25
▲ Buy · 🎯$50
Price at call : $41.8 — upside +20%
Today : $59.25 — upside -16%
Expected +20% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 64.8% · +20.2% (105 calls)
+42.9%
stock +43% · XLV +20%
matured Jun 26, 26
■ Neutral neutral · not a buy · 🎯$40
Price at call : $36.34 — gap to target +10%
Today : $59.25 — gap to target -32%
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 22, 26
matures : May 22, 26
■ Neutral neutral · not a buy · 🎯$45
Price at call : $37.52 — gap to target +20%
Today : $59.25 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
▲ Overweight · 🎯$46
Price at call : $37.52 — upside +23%
Today : $59.25 — upside -22%
Expected +23% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+15.3%
stock +15% · XLV +8%
matured May 8, 26
Goldman Sachs ↗
May 8, 25
■ Neutral neutral · not a buy · 🎯$45
Price at call : $37.52 — gap to target +20%
Today : $59.25 — gap to target -24%
🎯 on BRKR : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
■ Hold neutral · not a buy · 🎯$48
Price at call : $37.52 — gap to target +28%
Today : $59.25 — gap to target -19%
🎯 on BRKR : no call matured yet · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
Wells Fargo ↗
Apr 17, 25
▲ Overweight · 🎯$60
Price at call : $35.98 — upside +67%
Today : $59.25 — upside +1%
Expected +67% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 100% (2 calls matureds) · 📊 on Health : 47% · +4.6% (149 calls)
+14.2%
stock +14% · XLV +11%
matured Apr 17, 26
▲ Overweight · 🎯$50
Price at call : $38.76 — upside +29%
Today : $59.25 — upside -16%
Expected +29% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+0.8%
stock +1% · XLV +8%
matured Apr 10, 26
▲ Buy · 🎯$50
Price at call : $36.36 — upside +38%
Today : $59.25 — upside -16%
Expected +38% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 100% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
+5.2%
stock +5% · XLV +13%
matured Apr 7, 26
Guggenheim ↗
Feb 24, 25
▲ Buy
Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
-21.8%
stock -22% · XLV +6%
matured Feb 24, 26
■ Hold neutral · not a buy · 🎯$57
Price at call : $50.75 — gap to target +12%
Today : $59.25 — gap to target -4%
🎯 on BRKR : no call matured yet · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Feb 14, 26
matures : Feb 14, 26
▲ Overweight · 🎯$60
Price at call : $50.04 — upside +20%
Today : $59.25 — upside +1%
Expected +20% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 75% (4 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-23.8%
stock -24% · XLV +9%
matured Feb 14, 26
Maxim Group
Sep 27, 13
▲ Buy · 🎯$27
Price at call : $20.54 — upside +31%
Today : $59.25 — upside -54%
Expected +31% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BRKR : 0% (1 call matured) · 📊 on Health : 0% · -39.1% (4 calls)
-8.0%
stock -8% · XLV +27%
matured Sep 27, 14
Frequently asked questions
Should I buy Bruker stock?
This isn't buy advice. For Bruker, the analyst consensus is "Buy", with an average price target of $60.00 (+1% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Bruker). We show the numbers — you decide.
Is it too late to buy Bruker? How high can it go?
The most bullish analyst target on Bruker is $70.00 (+18% above today's price); the average is $60.00. That's the upside they see. Check how reliable those analysts have actually been on Bruker on our site before trusting it.
Is Bruker still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on Bruker, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Bruker? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BRKR (and why hesitate).
What has Bruker's past performance been?
Historical returns and a "how much if I had invested" calculator: BRKR performance & returns.
Does Bruker pay a dividend?
Yield, consistency and growth history of the dividend: BRKR's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX